Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022542
Filing Date
2020-05-07
Accepted
2020-05-07 12:02:02
Documents
87
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atnx-10q_20200331.htm 10-Q 2272313
2 EX-10.11.2 atnx-ex10112_208.htm EX-10.11.2 40789
3 EX-10.11 atnx-ex1011_206.htm EX-10.11 289636
4 EX-10.13 atnx-ex1013_207.htm EX-10.13 390613
5 EX-31.1 atnx-ex311_8.htm EX-31.1 18745
6 EX-31.2 atnx-ex312_6.htm EX-31.2 18397
7 EX-32.1 atnx-ex321_7.htm EX-32.1 11620
  Complete submission text file 0001564590-20-022542.txt   11179892

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT atnx-20200331.xml EX-101.INS 2747182
9 XBRL TAXONOMY EXTENSION SCHEMA atnx-20200331.xsd EX-101.SCH 71954
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atnx-20200331_cal.xml EX-101.CAL 64090
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atnx-20200331_def.xml EX-101.DEF 259794
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20200331_lab.xml EX-101.LAB 552783
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20200331_pre.xml EX-101.PRE 455560
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

EIN.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38112 | Film No.: 20855294
SIC: 2834 Pharmaceutical Preparations